CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Chiron Corp. announced Wednesday that it is ending the development of three compounds, including a recombinant form of interleukin-2 being studied in a Phase III trial for the treatment of patients with HIV. The company had been expected to complete the clinical trial, including patient follow-up, in 2007. Chiron is now reviewing data for a possible regulatory submission for approval of IL-2 only in a small subset of HIV-positive patients who do not receive any response to other anti-HIV medications. The company also stopped development of compounds intended to treat cystic fibrosis and hepatitis B.
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
These 15 major companies caved to the far right and stopped DEI programs
January 24 2025 1:11 PM
True
Latest Stories
LGBTQ+ and other leaders call Pope Francis progressive and transformative
April 21 2025 5:15 PM
Trump Administration to defund suicide hotline for LGBTQ+ youth starting in October
April 21 2025 3:54 PM
Sasha Colby's 'Stripped II' tour spotlights the trans experience
April 21 2025 3:42 PM
20 years of Sapphic cinema: the 20 best lesbian movies
April 21 2025 1:23 PM
Senate staffer accused of having sex in Capitol building recounts 'horrific' backlash
April 21 2025 12:03 PM